A Study to Examine Respiratory Combination Vaccines Against Respiratory Syncytial Virus (RSV) and Flu in Older Adults
Clinical trial NCT05788237 · COMPLETED
Trial details
- NCT number
- NCT05788237
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-09
- Primary completion
- 2023-09-27
- Enrollment
- 508
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.